Adeia

ADEANASDAQUSD

THESIS ALERT

Email me when the ADEA thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$17.13
+$0.88 (+5.38%)Today 1M −31.98%
After hours$16.79−1.96%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$16.25
Prior regular-session close from the quote source.
$16.45–$17.26
Regular-session low and high so far today.
1.1M
Regular-session shares traded · Nov 11, 4:00 PM ET.
Not yet confirmed
The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
$11.61–$34.34
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own ADEA if Adeia converts a large, internally-generated patent portfolio into high-margin, recurring licensing cash flow; lumpy upfront deals drive growth while the IP base and ongoing R&D protect pricing power in media and semiconductor markets.

ADEA price history

Latest price$17.13Today+$0.88 (+5.38%)
ADEA -27.30%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

5 MATERIAL PROPOSITIONS
  • Adeia's licensing model will sustain high operating margins because licensing has low incremental cost and portfolio-level pricing power that keeps amortization and litigation from eroding core operating profit.StrengtheningMateriality: High

    Operating income increased from $128,609,000 (FY 2024) to $175,003,000 (FY 2025) (fundamentals). If margins hold, the business converts revenue into operating income and cash efficiently, justifying the current multiple; if margins compress, valuation and FCF will suffer materially.

    Watch: Adverse court or ITC rulings that invalidate or narrow key patents, removing leverage in licensing negotiations.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Operating income increased from $128,609,000 (FY 2024) to $175,003,000 (FY 2025) (fundamentals).

    Open source ↗
  • A growing base of recurring royalties will stabilize operating cash flow and support continued debt reduction and capital returns.HoldingMateriality: High

    Operating cash flow remained positive at $158,086,000 in FY 2025 (fundamentals), supporting operations and capital allocation. Predictable recurring royalties make cash flows less lumpy and reduce dependence on volatile upfront deals — enabling steady deleveraging and optional shareholder returns.

    Watch: Concentration risk: a decline in royalties from large Pay-TV or specific semiconductor customers (customer-level renegotiation or volume declines) would depress recurring cash.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Operating cash flow remained positive at $158,086,000 in FY 2025 (fundamentals), supporting operations and capital allocation.

    Open source ↗
  • Growth and the market's valuation rely materially on periodic large upfront license agreements; absent similar deals, top-line growth and investor returns will underperform expectations.HoldingMateriality: Medium

    Revenue rose 18% to $443,386,000 in 2025, primarily driven by a new long-term license agreement with Disney recognized in Q4 2025 (MD&A / fundamentals). If future growth requires repeat of Disney-sized upfronts, the stock is dependent on deal cadence rather than steady organic royalty growth; a drought in large deals will reveal valuation downside.

    Watch: A lower cadence of large upfront license agreements (e.g., major customers refusing upfront structures) would reduce spikes in revenue and EPS.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Revenue rose 18% to $443,386,000 in 2025, primarily driven by a new long-term license agreement with Disney recognized in Q4.

    Open source ↗
  • Adeia's scale (≈13,750 patent assets, ~80% from internal innovation) provides a durable moat and positions it to capture growing semiconductor/AI-related licensing demand.StrengtheningMateriality: Medium

    Item 1 states ~13,750 media and semiconductor patent assets and ~80% internal innovation (Item 1 Business). If the portfolio remains relevant to semiconductors and AI (hybrid bonding, advanced packaging, thermal solutions), Adeia can grow higher-margin royalty streams as AI infrastructure expands; if relevance fades, royalty upside evaporates.

    Watch: A technological shift in semiconductor manufacturing or packaging that bypasses Adeia-covered inventions would reduce the addressable market.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Item 1 states ~13,750 media and semiconductor patent assets and ~80% internal innovation (Item 1 Business).

    Open source ↗
  • Adeia can continue modest deleveraging using FCF (principal payments and repurchases are manageable), but a large litigation settlement or sustained cash-flow hit would halt progress and force trade-offs.StrengtheningMateriality: Medium

    Liabilities decreased from $701,390,000 (2024) to $558,762,000 (2025) (fundamentals), and MD&A notes $60.4 million in principal payments and $20.0 million in repurchases in 2025 (MD&A). Deleveraging reduces interest expense and risk; if halted, leverage-sensitive valuation multiples could re-rate lower and capital returns could be cut.

    Watch: A multi-hundred-million-dollar adverse litigation judgment or required settlement would reverse deleveraging and could force asset impairments.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Liabilities decreased from $701,390,000 (2024) to $558,762,000 (2025) (fundamentals), and MD&A notes $60.4 million in principal payments and $20.0 million.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Adeia's licensing model will sustain high operating margins because licensing has low incremental cost and portfolio-level pricing power that keeps amortization and litigation from eroding core operating profit. If margins hold, the business converts revenue into operating income and cash efficiently, justifying the current multiple; if margins compress, valuation and FCF will suffer materially.

A growing base of recurring royalties will stabilize operating cash flow and support continued debt reduction and capital returns. Predictable recurring royalties make cash flows less lumpy and reduce dependence on volatile upfront deals — enabling steady deleveraging and optional shareholder returns.

Growth and the market's valuation rely materially on periodic large upfront license agreements; absent similar deals, top-line growth and investor returns will underperform expectations. If future growth requires repeat of Disney-sized upfronts, the stock is dependent on deal cadence rather than steady organic royalty growth; a drought in large deals will reveal valuation downside.

Adeia's scale (≈13,750 patent assets, ~80% from internal innovation) provides a durable moat and positions it to capture growing semiconductor/AI-related licensing demand. If the portfolio remains relevant to semiconductors and AI (hybrid bonding, advanced packaging, thermal solutions), Adeia can grow higher-margin royalty streams as AI infrastructure expands; if relevance fades, royalty upside evaporates.

Adeia can continue modest deleveraging using FCF (principal payments and repurchases are manageable), but a large litigation settlement or sustained cash-flow hit would halt progress and force trade-offs. Deleveraging reduces interest expense and risk; if halted, leverage-sensitive valuation multiples could re-rate lower and capital returns could be cut.

All standing thesis claims
Original report summary

Adeia converts a large, internally-generated patent portfolio into high-margin, recurring licensing cash flow; lumpy upfront deals drive growth while the IP base and ongoing R&D protect pricing power in media and semiconductor markets.

Evidence assessed Nov 4, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for Adeia

Where the evidence on Adeia stands: Holding on the latest evidence (Nov 4, 2026). Of its 5 thesis points, 3 strengthening and 2 holding.

Bull case: what the evidence supports

  • Adeia's licensing model will sustain high operating margins because licensing has low incremental cost and portfolio-level pricing power that keeps amortization and litigation from eroding core operating profit.

    sec.gov ↗

  • A growing base of recurring royalties will stabilize operating cash flow and support continued debt reduction and capital returns.

    sec.gov ↗

  • Growth and the market's valuation rely materially on periodic large upfront license agreements; absent similar deals, top-line growth and investor returns will underperform expectations.

    sec.gov ↗

  • Adeia's scale (≈13,750 patent assets, ~80% from internal innovation) provides a durable moat and positions it to capture growing semiconductor/AI-related licensing demand.

    sec.gov ↗

  • Adeia can continue modest deleveraging using FCF (principal payments and repurchases are manageable), but a large litigation settlement or sustained cash-flow hit would halt progress and force trade-offs.

    sec.gov ↗

Bear case: what would count against it

  • Adverse court or ITC rulings that invalidate or narrow key patents, removing leverage in licensing negotiations.

    sec.gov ↗

  • Concentration risk: a decline in royalties from large Pay-TV or specific semiconductor customers (customer-level renegotiation or volume declines) would depress recurring cash.

    sec.gov ↗

  • A lower cadence of large upfront license agreements (e.g., major customers refusing upfront structures) would reduce spikes in revenue and EPS.

    sec.gov ↗

Thesis-Break Engine

What has broken in Adeia’s thesis

Each break OptimistFi flagged on Adeia, dated — with what has historically followed the same kind of break across the market, not a forecast for Adeia.

  • CEO / officer changecondition set before this filing

    Across all companies, this kind of break has happened 16,849 times before. Those stocks trailed comparable companies by a median of 2% over the next six months, and 38% of them trailed it by 10 points or more.

How the Thesis-Break Engine works →Historical outcomes are measured against comparable companies after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Reported results of operations (earnings release).

    Adeia filed an SEC 8-K on 2026-11-02: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  2. Mixed
    Director or principal officer change.

    Adeia filed an SEC 8-K on 2026-09-28: Director or principal officer change. It is a dated development that tests the current thesis.

  3. Mixed
    Reported results of operations (earnings release).

    Adeia filed an SEC 8-K on 2026-08-03: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • Adverse court or ITC rulings that invalidate or narrow key patents, removing leverage in licensing negotiations.
  • Concentration risk: a decline in royalties from large Pay-TV or specific semiconductor customers (customer-level renegotiation or volume declines) would depress recurring cash.
  • A lower cadence of large upfront license agreements (e.g., major customers refusing upfront structures) would reduce spikes in revenue and EPS.
  • A technological shift in semiconductor manufacturing or packaging that bypasses Adeia-covered inventions would reduce the addressable market.
  • A multi-hundred-million-dollar adverse litigation judgment or required settlement would reverse deleveraging and could force asset impairments.

ADEA news

Loading headlines…

Financial statements

ADEA income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

ADEA: quick answers

Which well-known investors own ADEA?
1 of the 37 well-known funds tracked here reported ADEA shares in their latest 13F filing. By share of the fund's portfolio: Soros Fund Management (George Soros), 0.0%. Fund portfolios

ADEA in well-known investors’ portfolios

1 of 37 funds reported ADEA shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.

FundOf its portfolioValueChangeQuarter
George SorosSoros Fund Management0.00%$365K−78.0%Q2 2026

Every fund’s portfolio

ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.